Geographic location was seen to affect disease stage at diagnosis among people with colorectal cancer who live in ethnically or racially segregated communities.
Clinical breast examination (CBE) is superior to MRI for predicting pathologic complete response (pCR) in women with HER2-positive breast cancer, a study presented at the 2016 San Antonio Breast Cancer Symposium indicates.
More melanomas are self-detected by women; men tend to have more melanomas in less visible locations.
Patient navigation reduces delays in diagnostic resolution among patients with a Charlson Comorbidity Index greater than 1 with abnormal findings
DNA methylation profiling identified the primary cancer in cases of cancer of unknown primary, informing tumor-type specific treatment that improved overall survival in these patients.
Breath analysis offers an option for both primary screening and postsurgery monitoring of patients with lung cancer. Exhaled breath has certain carbonyl VOCs that indicate the presence of lung cancer in a process researchers hope will receive FDA approval.
Symptoms of posttraumatic stress disorder (PTSD) develop in a majority of patients with breast cancer, and these symptoms persist for at least a year for most.
More than 3 months from surgery to chemotherapy and increasing delays from diagnosis to surgery in patients with breast cancer are associated with increased risk of death from the disease.
Blood samples collected from the portal vein can tell physicians far more about a patient's pancreatic cancer than peripheral blood collected from a more easily accessed vein in the arm.
A personalized testing method may quickly and more accurately predict the effectiveness of a treatment for multiple myeloma in individual patients. The process may also aid patients with leukemia or lymphoma.
Affordable Care Act (ACA) Impacts Stage at Diagnosis and Fertility-Sparing Treatment in Young Women With Cervical CancerNovember 30, 2015
Both the stage of cervical cancer at diagnosis and the receipt of fertility-sparing treatment among young women age 21 to 25 years, but not among women age 26 to 34 years, is associated with the Affordable Care Act Dependent Coverage Expansion provision.
A new test is better at detecting aggressive prostate cancer than measuring PSA levels. The new test discovers aggressive cancer earlier and reduces the number of false positive tests and unnecessary biopsies.
RNA test of blood platelets can detect, classify, and pinpoint the location of cancer by analyzing a sample equivalent to 1 drop of blood. Using this new method, researchers were able to identify cancer with 96% accuracy.
The genetic landscape of fibroepithelial tumors has been uncovered. The culprit genes behind the formation and progression of these tumors were identified, potentially improving the diagnostic accuracy of breast cancer and enhancing clinical intervention for patients with this tumor type.
Researchers report that CRC tumors in younger persons may be molecularly distinct from those of older persons, and that these differences are related to epigenetics of the tumors in younger patients.
A new proof of principle study seems to validate the usefulness of DNA testing to detect cancers in the oral cavity.
A seemingly innocuous injury to the foot produces a persistent lesion. Punch biopsy reveals an unusual diagnosis.
New diagnoses of prostate cancer have declined in the U.S. following the 2011 USPSTF draft recommendation regarding the use of prostate-specific antigen (PSA)-based screenings.
CHICAGO, IL—Functional subtyping with a multigene classifier resulted in 1 in 5 tumors being reclassified compared with conventional immunohistochemistry/fluorescent in situ hybridization (IHC/FISH) analysis. This study was presented at the 2015 American Society for Clinical Oncology (ASCO) Annual Meeting.
Study data suggests that magnetic resonance imaging (MRI) could one day make biopsies more effective, or even replace them altogether, via noninvasive detection of telltale sugar molecules shed by the outer membranes of cancerous cells.
A comparison of the diagnostic interpretation of breast biopsy slides by pathologists and that of an expert consensus panel yielded an overall agreement of 75%.
Patients with multiple myeloma seem to have improves survival if they are found to have monoclonal gammopathy of undetermined significance (MGUS) first.
Researchers report 3 percent annual rise in intermediate- and high-risk cases
When diagnosed with cancer, individuals with diabetes are less likely to take their diabetes medication, especially in cases of a poor cancer prognosis.
A change in diagnosis resulted from PET/CT imaging of patients who were younger than 40 years with an initial diagnosis of stage I-III breast cancer, according to a retrospective analysis.
Routine use of a molecular testing panel greatly decreased the need for an initial lobectomy to confirm diagnosis in patients with thyroid nodules and cancer, reported researchers. The test improved the chances of patients undergoing the correct initial surgery by 30%.
Asking patients if a suspicious skin lesion is painful or itchy may help doctors decide whether the spot is likely to be cancerous, according to a new study.
Suspicious looking lesions that are painful or itchy should raise concerns for non-melanoma skin cancers, according to research from Temple University School of Medicine.
A research team from Japan found that 16-core biopsy has a slightly higher detection rate than 12-core biopsy.
The driving forces in the evolution of health care are the aging US population, an increasing cultural awareness of health and cancer, and recognition of patients as consumers.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|